Abivax Adr (ABVX)

Jun 12, 2025

Abivax’s Potential in IBD Market: Buy Rating Backed by Phase 3 Trials and Industry Trends - TipRanks

Jun 12, 2025

Jun 11, 2025

Abivax SA Shareholders Approve 2024 Financials and Board Appointments - TipRanks

Jun 11, 2025

Jun 11, 2025

Abivax Announces Results of its June 6, 2025 Annual General Meeting - GlobeNewswire Inc.

Jun 11, 2025

Jun 09, 2025

European ADRs Edge Up As Wisekey And ASML Lead Gains - Finimize

Jun 09, 2025

Jun 04, 2025

Promising Outlook for Abivax’s Obefazimod in Ulcerative Colitis with Upcoming Phase 3 Results as Key Catalyst - TipRanks

Jun 04, 2025

Jun 02, 2025

Abivax SA Reports Increased Losses Amid R&D Expansion - TipRanks

Jun 02, 2025

Jun 02, 2025

Abivax Reports First Quarter 2025 Financial Results with Increased R&D Costs - TipRanks

Jun 02, 2025

May 14, 2025

Optimistic Buy Rating for Abivax SA: Obefazimod’s Potential in Ulcerative Colitis and Market Opportunity - TipRanks

May 14, 2025

Apr 29, 2025

Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials - TipRanks

Apr 29, 2025

Apr 22, 2025

Abivax Announces AGM Details and Board Appointment Amid 2025 Milestones - TipRanks

Apr 22, 2025

Apr 18, 2025

Abivax ADR (NASDAQ: ABVX) – Does It Provide Stability And Growth? - Stocksregister

Apr 18, 2025

Apr 08, 2025

Abivax Reports 2024 Financial Results, Eyes Clinical Milestones - TipRanks

Apr 08, 2025

Mar 27, 2025

Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating - TipRanks

Mar 27, 2025

Mar 25, 2025

Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength - TipRanks

Mar 25, 2025

Mar 25, 2025

Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment - TipRanks

Mar 25, 2025

Mar 24, 2025

Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position - TipRanks

Mar 24, 2025

Mar 18, 2025

Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025 - TipRanks

Mar 18, 2025

Mar 17, 2025

Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment - TipRanks

Mar 17, 2025

Mar 01, 2025

Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High? - MSN

Mar 01, 2025

Feb 24, 2025

Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? - Nasdaq

Feb 24, 2025

Feb 11, 2025

Wall Street Analysts Think Abivax SA Sponsored ADR (ABVX) Could Surge 427.9%: Read This Before Placing a Bet - Yahoo Finance

Feb 11, 2025

Feb 10, 2025

Potential Price Increase for Abivax ADR (ABVX) After Recent Insider Activity - Knox Daily

Feb 10, 2025

Feb 10, 2025

Sibanye Stillwater Limited ADR (SBSW) rating downgrades by HSBC Securities - Knox Daily

Feb 10, 2025

Feb 07, 2025

Quantum Corp (QMCO) Stock: A Closer Look at the Market Potential - The News Heater

Feb 07, 2025

Feb 07, 2025

Analyzing the Price-to-Earnings Ratio of Abivax ADR (ABVX) - The News Heater

Feb 07, 2025

Feb 07, 2025

Capricor Therapeutics Inc (CAPR) Shares Plummet Below 1-Year High - The News Heater

Feb 07, 2025

Feb 07, 2025

Paylocity Holding Corp’s (PCTY) Stock: A Long-Term Performance Analysis - The News Heater

Feb 07, 2025

Feb 07, 2025

Perrigo Company plc (PRGO) Stock: A Closer Look at the Moving Averages - The News Heater

Feb 07, 2025

Feb 07, 2025

Analyzing the Price-to-Earnings Ratio of ICL Group Ltd (ICL) - The News Heater

Feb 07, 2025

Feb 07, 2025

Tectonic Therapeutic Inc (TECX) Stock: A Review of the Recent Movement - The News Heater

Feb 07, 2025

Feb 07, 2025

Healthcare Triangle Inc (HCTI) Stock: A Closer Look at the Market Potential - The News Heater

Feb 07, 2025

Jan 30, 2025

Here's Why Abivax SA Sponsored ADR (ABVX) is Poised for a Turnaround After Losing -19.81% in 4 Weeks - MSN

Jan 30, 2025

Oct 26, 2023

Citi Appointed as Depositary Bank for Abivax SA’s ADR Program - Business Wire

Oct 26, 2023